Innovator IBD 50 ETF Rating $37.79 +0.37 (+0.99%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Innovator IBD 50 ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FFTY Aggregate RatingModerate Buy 2.71Holdings in FFTY have an aggregate rating of Moderate Buy based on 390 analyst ratings issued in the past year covering 25 companies (73.9% of the portfolio).FFTY Aggregate Price Target$37.79High Prediction$37.79Average Prediction$37.79Low Prediction$37.79Holdings in FFTY have an aggregate price target of $37.79 and a range of $37.79 to $37.79 covering 25 companies (73.9% of the portfolio).FFTY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD 50 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FFTY Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.10%SEZLSezzle$128.96-0.7%4.1486 of 5 stars2.67$146.50 13.6%93.66%ENVAEnova International$265.93+1.5%3.4172 of 5 stars3.11$247.83 -6.8%93.61%LQDALiquidia$74.44+3.2%4.5367 of 5 stars2.64$98.08 31.8%11Trending NewsEarnings ReportAnalyst DowngradeAnalyst RevisionGap Up3.44%CARECarter Bankshares$32.70+0.1%3.0863 of 5 stars2.20$30.75 -6.0%53.39%SNSharkNinja$184.25-2.3%3.5776 of 5 stars2.92$188.59 2.4%13Analyst ForecastInsider Trade3.38%DAVEDave$334.57+0.2%4.3446 of 5 stars2.79$412.90 23.4%143.38%INDVIndivior$39.01+2.1%4.0331 of 5 stars2.86$45.17 15.8%7Positive News3.31%KNSAKiniksa Pharmaceuticals International$76.75-1.4%4.1824 of 5 stars2.90$87.38 13.8%10Positive News3.28%ECOOkeanis Eco Tankers$60.23-5.8%3.0324 of 5 stars2.67$59.52 -1.2%6Analyst UpgradeGap Down3.25%TGTXTG Therapeutics$48.74+1.7%4.3834 of 5 stars2.44$63.00 29.3%93.18%GKOSGlaukos$185.01-2.3%2.4257 of 5 stars2.73$177.33 -4.1%15Insider Trade3.11%KRYSKrystal Biotech$332.27+1.2%4.0541 of 5 stars2.92$365.40 10.0%13Positive NewsAnalyst Forecast3.04%OSCROscar Health$32.68+6.2%4.4238 of 5 stars2.42$26.22 -19.8%12Analyst Upgrade3.03%EXPEExpedia Group$332.69+1.3%4.5687 of 5 stars2.44$311.76 -6.3%39Analyst ForecastInsider Trade2.96%LLYEli Lilly and Company$1,182.24-2.2%4.732 of 5 stars2.83$1,292.18 9.3%30Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision2.83%EXELExelixis$51.24+1.2%3.1006 of 5 stars2.32$49.79 -2.8%19Analyst UpgradeInsider Trade2.65%NBIXNeurocrine Biosciences$152.72+1.3%4.9877 of 5 stars2.88$200.86 31.5%24Analyst Downgrade2.61%DDOGDatadog$255.46+1.3%4.0522 of 5 stars2.91$276.32 8.2%45Trending NewsAnalyst UpgradeInsider Trade2.58%ESTAEstablishment Labs$79.47+5.1%3.1773 of 5 stars2.78$100.25 26.1%9Analyst Upgrade2.45%RSIRush Street Interactive$25.60+4.0%4.6366 of 5 stars2.92$35.22 37.6%13Positive News2.19%PAYPaymentus$41.90-0.7%2.2271 of 5 stars2.57$38.67 -7.7%7Positive News2.19%VCTRVictory Capital$118.24+0.1%4.1308 of 5 stars2.67$98.29 -16.9%9Positive NewsAnalyst Upgrade2.11%NETCloudflare$315.63-4.6%3.799 of 5 stars2.64$320.19 1.4%33Insider Trade2.10%SKWDSkyward Specialty Insurance Group$59.80+1.4%4.6801 of 5 stars2.85$68.64 14.8%13Positive NewsAnalyst Forecast2.10%STTState Street$191.92+1.1%4.871 of 5 stars2.81$185.38 -3.4%16 This page (NYSEARCA:FFTY) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredOne wafer-scale chip does in minutes what AI takes daysNVIDIA has dominated the AI computing race, but history shows even titans can be dethroned, just ask IBM. T...Eagle Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.